Webcast - Diagnostics of SARS-CoV-2
The ability to detect and trace SARS-CoV-2 throughout the population is fundamental to the success of any COVID-19 management strategy, but the different tests available have advantages and disadvantages with crucial implications for how screening programmes are managed and administered.
In this webcast, three world-renowned experts, Professor Jean-Michel Pawlotsky, Professor Jon Deeks and Professor Mario Mondelli, discuss the current state of COVID-19 diagnostics. Opening with an explanation of virological markers and their development over the course of infection, and the capabilities of different testing modalities, the experts discuss key challenges such as reliability and limited sensitivity in asymptomatic patients, and the practicalities of evaluating diagnostic tools in real-world use.
In doing so, the experts evaluate how current diagnostic capabilities can be best used to establish risk, identify disease in individuals and to track the spread of SARS-CoV-2 within the population.
- Understand the development of virological markers during the infection
- Apprehend the modalities of the different tests available
- Learn more about the reliability and limited sensitivity of the tests in asymptomatic patients
- Understand how to establish risk, identify disease and track the spread of SARS-CoV-2 within the population
- General practitioners
- Health care professionals
- Clinical researchers and scientists
If you wish to obtain a certificate of completion for this webcast, please click here.
|Mario Mondelli is Professor of Infectious Diseases at Pavia University and Head of the Division of Clinical Immunology and Infectious Diseases at Fondazione IRCCS Policlinico San Matteo in Pavia, Italy. Professor Mondelli’s research interests focus on immune responses in viral hepatitis and liver cancer and, more recently, in COVID-19. He served as Secretary General of the European Association for the Study of the Liver (EASL) from 1995–1997 and was Associate Editor and Co-editor of the Journal of Hepatology from 1999–2009. Among his many achievements, Professor Mondelli received the EASL Recognition Award in 2018.|
Jean-Michel Pawlotsky is Professor of Medicine at the University of Paris-Est. He is the Director of the National Reference Center for Viral Hepatitis B, C and D and of the Department of Virology at the Henri Mondor University Hospital in Créteil, France, and Director of research team “Viruses-Hepatology-Cancers“ at the Mondor Institute of Biomedical Research (INSERM U955). He focuses on teaching and research in virology (primarily hepatitis viruses) and liver oncology.
Jon Deeks is Professor of Biostatistics and Head of the Biostatistics, Evidence Synthesis and Test Evaluation Research Group at the Institute of Applied Health Research, part of the College of Medical and Dental Services at the University of Birmingham, UK. He is also the UK National Institute of Health Research Senior Investigator Emeritus. Professor Deeks’ research interests focus on the evaluation of healthcare interventions and medical tests, and he leads the Cochrane Collaboration’s test evaluation activities, as well as advising the World Health Organization on test evaluation methods.